COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)
$22.09 -0.02 (-0.0905%)
Analysed COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) News Sources
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress
06-08-2026
yahoo.com
Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops
06-08-2026
yahoo.com
Collegium Pharmaceutical Q2 Earnings Call Highlights
06-08-2026
marketbeat.com
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance
10-08-2026
yahoo.com
Collegium Announces $50 Million Accelerated Share Repurchase Program
13-08-2026
yahoo.com
Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript
13-08-2026
fool.com
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call
15-08-2026
yahoo.com
3 Value Stocks That Fall Short
28-09-2026
yahoo.com
Collegium Launches "Start Talking ADHD" with Practical Support to Help Families Navigate Care, School and Everyday Life
06-10-2026
yahoo.com
Collegium Pharmaceutical Outlook Supported by ADHD Trends, Low Generic Drug Risk, Oppenheimer Says
09-10-2026
yahoo.com
What is the current price of COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)?
The current price of COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) is $22.09.
COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) absolute price change since previous trading day?
The absolute price change of COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) since the previous trading day is $-0.02.
COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) percentage price change since previous trading day?
The percentage price change of COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) since the previous trading day is -0.0905%.
What is the most recent average sentiment score for COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)?
The most recent average sentiment score for COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)?
The most recent sentiment for COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) is .
SEC-8K** Filing Available For COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.